The forecast for bladder malignant neoplasms mortality among women in Germany indicates a gradual decline over the forecasted period from 2024 to 2028. The rate is expected to decrease from 2.5 per hundred thousand women in 2024 and 2025 to 2.3 in 2028. This downward trend suggests improvements in medical treatment or prevention efforts. Given the rates were consistent at 2.5 in 2023, the year-on-year variation between 2025 and 2026 is approximately a 4% decrease, and a similar decline continues through to 2028. The compound annual growth rate (CAGR) over the five-year period is minimal, reflecting steady but modest improvement.
Future trends to watch for include advancements in early detection of bladder cancer, which may further reduce mortality rates. Additionally, monitoring changes in risk factors such as smoking and exposure to carcinogens, as well as improvements in treatment efficacy, will be crucial. Continued investments in healthcare infrastructure and public health interventions could accelerate the decline in mortality rates.
